Addison Capital’s Medicines Co MDCO Stock Holding History

Addison Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,983	Closed	-$355K	–	123
2017 Q4	$355K	Buy	+12,983	New	+$400K	0.28%	87
2017 Q2	–	Sell	-4,759	Closed	-$233K	–	106
2017 Q1	$233K	Sell	4,759 -1,307	-22%	-$59.6K	0.19%	96
2016 Q4	$206K	Hold	6,066	–	–	0.18%	94
2016 Q3	$229K	Sell	6,066 -10,198	-63%	-$384K	0.2%	89
2016 Q2	$547K	Buy	+16,264	New	+$573K	0.49%	69
2015 Q2	–	Sell	-13,410	Closed	-$376K	–	104
2015 Q1	$376K	Buy	13,410 +4,691	+54%	+$132K	0.31%	68
2014 Q4	$241K	Buy	+8,719	New	+$216K	0.2%	73

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Addison Capital's MDCO Position: Q1 2018 in Review

Addison Capital sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 12,983 shares — an estimated $355K sold.

Addison Capital first reported a position in MDCO in Q4 2014 and held it in 7 quarters. The position peaked at $547K in Q2 2016. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

Addison Capital reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
Addison Capital sold 12,983 Medicines Co shares in Q1 2018, an estimated $355K.
Addison Capital first reported a position in Medicines Co in Q4 2014 and held it in 7 quarters.
Addison Capital's Medicines Co position peaked at $547K in Q2 2016.
190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Addison Capital's 13F filing for Q1 2018, filed 10 Apr 2018.